Michael E. Beil

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 167 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +10

Pharmacodynamic and Pharmacokinetic Characterization of the Aldosterone Synthase Inhibitor FAD286 in Two Rodent Models of Hyperaldosteronism: Comparison with the 11β-Hydroxylase Inhibitor Metyrapone

Dean F. Rigel, Fumin Fu, Michael E. Beil et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 57 citations

Medicine, Pharmacokinetics, Pharmacology +11

Aldosterone synthase inhibition: cardiorenal protection in animal disease models and translation of hormonal effects to human subjects

Joël Ménard, Dean F. Rigel, Catherine E. Watson et al. · Journal of Translational Medicine · 2014 · 56 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17

Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.

N Levens, Michael E. Beil · Journal of Pharmacology and Experimental Therapeutics · 1991 · 49 citations

Medicine, Nephrology, Pharmacology +17

Discovery and in Vivo Evaluation of Potent Dual CYP11B2 (Aldosterone Synthase) and CYP11B1 Inhibitors

Erik L. Meredith, Gary M. Ksander, Lauren G. Monovich et al. · ACS Medicinal Chemistry Letters · 2013 · 48 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16